BXRXQ

0.00010.00%
WB

Wayne B. Weisman

Independent Chairman

Mr. Wayne B. Weisman J.D., is Chairman of Garnet Biotherapeutics, Inc. Mr. Weisman was Director of Garnet Biotherapeutics, Inc. Mr. Weisman, serves as Director at Echo 360 Holdings, Inc. He has been an Independent Director of Baudax Bio, Inc. since 2019 and serves as its Chairman since May 02, 2022. Mr. Weisman serves as Partner of SCP Partners since its inception in 1996. He led the firm's efforts in the life sciences area and technological investments. He has been involved at private equity and venture capital investing since 1987. He is a Founder and Managing Partner of SCP Vitalife. Since 2007, Mr. Weisman has been a Director of the corporate general Partner of the common general Partner of SCP Vitalife. Mr. Weisman has been a Director of SCP Vitalife GP since 2007. He has also led the activities of SCP Private Equity Partners II, L.P. Mr. Weisman has also served as a managing Member of SCP Vitalife Management Company, LLC. He served as Principal of CIP Capital Inc. From January 1992 to May 1994, he served as an Executive Vice President of Affinity Biotech, Inc., where he had responsibility for strategic alliances, financial strategy and mergers and acquisitions. He served as a Managing Director at Churchill Investment Partners, Inc. since 1990. Mr. Weisman also served as Vice President and a Member of the Board of Directors at CIP Capital L.P. He also oversaw its initial public offering and merger into the CIP Capital L.P. that subsequently became IBAH, Inc. and served as its Vice President and General Counsel. From 1987 to 1990, he ran an independent investment management and financial advisory firm focusing on the reorganization and turnaround of troubled companies. From 1992 to 1994, Mr. Weisman was Executive Vice President and Member of the Board of Directors of a public drug delivery technology company. He began his career at the Philadelphia law firm of Saul, Ewing, Remick & Saul and practiced law with the Philadelphia firm. Mr. Weisman had been the Chairman of Societal CDMO, Inc. (formerly known as Recro Pharma, Inc.) since 2008 until April 2024 and also had been its Director since 2008 until April 2024 and served as its Executive Chairman of the Board since September 2023 until April 2024. He serves as Board Observer of Deep Breeze Ltd. He serves as a Director of blinkx, Inc. He serves as a Director of Echo360, Inc., CommerceQuest, Inc., blinkx, Inc., Gigared S.A., Deep Breeze Ltd., Trig Medical Ltd., Argo Medical Technologies, Integrated Computing Engines, Inc. He had been an Independent Director of ReWalk Robotics Ltd. since 2009 until September 13, 2023. He served as Director of EndoSpan Ltd. since 2009 until 2015. Mr. Weisman is a Director or Chairman of several companies, including DIR Technologies and LZ Therapeutics. Mr. Weisman has been a Director of CinemaStar Luxury Theaters, Inc. since December 1997 and CMT Corp. since May 1997. He has been a Director of Breakaway Solutions, Inc. since April 2001 and Microleague Multimedia, Inc. since March 1997. He served as Director at Ivenix, Inc. (formerly known as Fluidnet Corporation) since 2011 until 2015. He served as Director of Pocared Diagnostics Ltd. since 2007 until 2015. He serves on the Board of trustees of Young Scholars Charter School. He is the Chairman of the Board of trustees of Young Scholars School, Young Scholars Kenderton and Young Scholars Frederick Douglass. He is also an advisory board member of the Philadelphia-Israel Chamber of Commerce and Mid-Atlantic Diamond Ventures, the venture forum of Temple University. He served as the Chairman of Breakaway Solutions, Inc. since April 2001 and Anystream, Inc. He served as a Director of Icon CMT Corp. since May 1997. He served as a Director of Affinity Biotech, Inc. and CIP Capital L.P. He served as a Member of the Board of Directors of the Greater Philadelphia Venture Group. He has extensive experience in venture capital investing, particularly in the life sciences area, dating back to 1990. Mr. Weisman is a featured speaker and panelist at numerous venture capital and entrepreneurial forums. Mr. Weisman holds a J.D. from the University of Michigan Law School in 1982 and a B.A. cum laude from the University of Pennsylvania in 1978.

Positions